4996 related articles for article (PubMed ID: 3937276)
1. On the composition and function of the carbohydrate moiety of tissue-type plasminogen activator from human melanoma cells.
Rijken DC; Emeis JJ; Gerwig GJ
Thromb Haemost; 1985 Dec; 54(4):788-91. PubMed ID: 3937276
[TBL] [Abstract][Full Text] [Related]
2. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin.
Fischer B
Biomed Biochim Acta; 1991; 50(1):47-54. PubMed ID: 1830477
[TBL] [Abstract][Full Text] [Related]
3. Deglycosylation increases the fibrinolytic activity of a deletion mutant of tissue-type plasminogen activator.
Wilhelm J; Kalyan NK; Lee SG; Hum WT; Rappaport R; Hung PP
Thromb Haemost; 1990 Jun; 63(3):464-71. PubMed ID: 2119528
[TBL] [Abstract][Full Text] [Related]
4. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
Diamond MP; Kruger M; Saed GM
Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
[TBL] [Abstract][Full Text] [Related]
5. Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator.
Dodd I; Fears R; Robinson JH
Thromb Haemost; 1986 Feb; 55(1):94-7. PubMed ID: 3085269
[TBL] [Abstract][Full Text] [Related]
6. Functional effects of asparagine-linked oligosaccharide on natural and variant human tissue-type plasminogen activator.
Hansen L; Blue Y; Barone K; Collen D; Larsen GR
J Biol Chem; 1988 Oct; 263(30):15713-9. PubMed ID: 3139674
[TBL] [Abstract][Full Text] [Related]
7. Effects of N-glycosylation on in vitro activity of Bowes melanoma and human colon fibroblast derived tissue plasminogen activator.
Wittwer AJ; Howard SC; Carr LS; Harakas NK; Feder J; Parekh RB; Rudd PM; Dwek RA; Rademacher TW
Biochemistry; 1989 Sep; 28(19):7662-9. PubMed ID: 2514792
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
Lijnen HR; Wagner EF; Collen D
Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
[TBL] [Abstract][Full Text] [Related]
9. Hepatic clearance of tissue-type plasminogen activator in rats.
Emeis JJ; van den Hoogen CM; Jense D
Thromb Haemost; 1985 Oct; 54(3):661-4. PubMed ID: 3937264
[TBL] [Abstract][Full Text] [Related]
10. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
11. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
Korner G; Bjornsson TD; Vlodavsky I
J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
[TBL] [Abstract][Full Text] [Related]
14. Expression of human tissue-type plasminogen activator from lytic viral vectors and in established cell lines.
Sambrook J; Hanahan D; Rodgers L; Gething MJ
Mol Biol Med; 1986 Dec; 3(6):459-81. PubMed ID: 3039288
[TBL] [Abstract][Full Text] [Related]
15. Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain.
Stack MS; Gray RD; Pizzo SV
Cancer Res; 1993 May; 53(9):1998-2004. PubMed ID: 8481902
[TBL] [Abstract][Full Text] [Related]
16. N-glycosylation and in vitro enzymatic activity of human recombinant tissue plasminogen activator expressed in Chinese hamster ovary cells and a murine cell line.
Parekh RB; Dwek RA; Rudd PM; Thomas JR; Rademacher TW; Warren T; Wun TC; Hebert B; Reitz B; Palmier M
Biochemistry; 1989 Sep; 28(19):7670-9. PubMed ID: 2514793
[TBL] [Abstract][Full Text] [Related]
17. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
[TBL] [Abstract][Full Text] [Related]
18. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
de Vries TJ; Kitson JL; Silvers WK; Mintz B
Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
[TBL] [Abstract][Full Text] [Related]
19. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
20. Isolation, identification and pharmacokinetic properties of human tissue-type plasminogen activator species: possible localisation of a clearance recognition site.
Dodd I; Nunn B; Robinson JH
Thromb Haemost; 1988 Jun; 59(3):523-8. PubMed ID: 3142086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
